Boothbay Fund Management »

Cullinan Oncology shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Cullinan Oncology (CGEM) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Cullinan Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cullinan Oncology held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cullinan Oncology by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $13M 1.2M 10.35
2021-06-30 $1.0M 39k 25.75

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Amazon Put Option (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Palantir Technologies Cl A Put Option (PLTR)
Abivax Sa Sponsored Ads (ABVX)
Alphabet Cap Stk Cl C Put Option (GOOG)
Mineralys Therapeutics Put Option (MLYS)
Advanced Micro Devices (AMD)
Microsoft Corporation (MSFT)
Invesco Exch Traded Fd Tr Ii S&p Midcp Low Call Option (XMLV)
Spdr Gold Tr Gold Shs Put Option (GLD)
Apple (AAPL)

View all positions for Boothbay Fund Management

Top funds holding Cullinan Oncology

MPM Oncology Impact Management
Lynx1 Capital Management
BVF
BlackRock
Vanguard Group
Blue Owl Capital Holdings
Kynam Capital Management
State Street Corporation
Citadel Advisors
Affinity Asset Advisors
OrbiMed Advisors
Rtw Investments
VR Adviser
Geode Capital Management
Boothbay Fund Management

View all funds holding Cullinan Oncology